The Best of Canadian Science and Technology
Raymond James analyst Rahul Sarugaser delivered an update to clients on Cardiol Therapeutics (Cardiol Therapeutics Stock Quote, Chart, News TSX:CRDL) … [Read more...] about Raymond James trims price target on Cardiol Therapeutics
A delay in commercialization is cause for a lowering of the price target for Cardiol Therapeutics (Cardiol Therapeutics Stock Quote, Chart, News … [Read more...] about Cardiol Therapeutics has price target trimmed at AltaCorp Capital
AltaCorp Capital analyst David Kideckel issued an update to clients on Cardiol Therapeutics (Cardiol Therapeutics Stock Quote, Chart, News TSX:CRDL) … [Read more...] about Cardiol Therapeutics has tremendous upside, AltaCorp Capital says
With a Shoppers Drug deal in hand and clinical trials in the works, things are just getting started for Cardiol Therapeutics (Cardiol Therapeutics … [Read more...] about Cardiol Therapeutics is a double, says Raymond James
With all the bad news in the cannabis sector and the market in general, there’s a ray of sunshine for Cardiol Therapeutics (Cardiol Therapeutics Stock … [Read more...] about Cardiol Therapeutics gets target raise at Raymond James on Shoppers Drug Mart deal
Cannabinoid company Cardiol Therapeutics (Cardiol Therapeutics Stock Quote, Chart, News TSX:CRDL) received a coverage launch from Raymond James last … [Read more...] about A Cannabinoid-based treatment for heart disease? Cardiol Therapeutics is one to watch, says Raymond James
A new report from investment banker Raymond James singles out a handful of companies that it says are taking the right steps to profit from the … [Read more...] about These five companies are doing CBD right, says Raymond James
